The Spectrum of Inter- and Intraventricular Conduction Abnormalities in Patients Eligible for Cardiac Resynchronization Therapy

Although cardiac resynchronization therapy (CRT) has clearly demonstrated its clinical benefit in patients with congestive heart failure (CHF) and intraventricular conduction abnormalities, selection of eligible patients and/or optimal pacing site are still a matter of debate. The aim of the study w...

Ausführliche Beschreibung